Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo
Highlights
► In this study we used dendrosomes to improve the bioavailability of curcumin. ► Dendrosomal curcumin significantly effects cancer cells rather than normal ones. ► Dendrosomal curcumin suppresses tumor growth in vivo. ► This effect is coupled with the induction of immune response.
Introduction
Cancer is defined as an intricate progressive multistep disease resulting from deregulation of several genes in different cellular pathways that lead to transformation of normal cells to malignant ones. Despite recent intensive attempts in understanding the molecular basis of tumor cells as well as successful targeted therapies for a limited number of tumor types, cancer remains to be one of the main causes of death worldwide [1]. On the basis of this idea and numerous epidemiological findings that diet plays a major role in cancer prevention, recent efforts have focused on traditional medicine (e.g. spices used in dietary) as a rich source of effective phytochemicals and their potential profits in treatment of chronic diseases especially cancer [1], [2]. Curcumin is the flavoring agent of turmeric powder (Curcuma longa) with various therapeutic properties especially anti-tumor activity without any side effects on normal cells [3]. Its anti-tumor activities embrace cancer growth inhibition and apoptosis induction by modulating different signal transduction pathways in vitro and in vivo [4]. In spite of these tempting attributes of curcumin, insolubility of the compound in aqueous solutions, actually the main reason for its poor bioavailability in vivo, has limited its exploitation as therapeutic agent [5]. To overcome this problem and increase the solubility of curcumin, numerous approaches have been taken by using adjuvants, liposomes and more recently nanoparticles [6], [7], [8], [9]. However, there has not been found any perfect formulation yet.
Here, we improved the solubility of curcumin thereby its anti-cancerous property by employing dendrosome nanoparticles in vitro and in vivo. Dendrosome is a neutral, amphipathic and biodegradable nano-material synthesized previously by our group and its capability has been shown in safely delivering genes into different cell lines [10], [11]. Our data for the first time reveals that dendrosome not only boosts the solubility of curcumin and its uptake in cell lines but also increases its toxicity on cancer cells rather than healthy ones. Meanwhile, our in vivo work with fibrosarcoma models in BALB/c mice suggests that dendrosomal curcumin compound suppresses tumor growth, coupled with induction of immune response against cancer cells.
Section snippets
Cells and reagents
Three cell lines including BALB/c mouse fibrosarcoma cell line WEHI-164, normal mouse embryonic fibroblast cell line MEF (both from Pasteur Institute, Tehran, Iran) and human epidermoidzcarcinoma cell line A431 (ATCC-Nr. CRL-1255) were grown in Dulbecco's modified Eagle's medium (DMEM; GIBCO, USA) containing 10% fetal bovine serum (FBS; GIBCO, USA) at 37 °C in a humidified atmosphere of 5% CO2. Curcumin was purchased from Sigma-Aldrich Company, USA. Dendrosome nanoparticle specified Den O400, a
Uptake kinetics of dendrosomal curcumin
Dendrosomal curcumin and void curcumin were dispersed in PBS. Fig. 1A indicates that dendrosomal curcumin was stably dispersed even after 24 h while curcumin powder began precipitating 1 h after dispersion and the pellet was clearly seen one day later. The homogenized feature of curcumin in dendrosomal curcumin configuration could be viewed by light and U.V. microscopy in Fig. 1B, but void curcumin aggregates as crystal bodies with different sizes. Also, the absorbance spectrum of dendrosomal
Discussion
The previous reports have proven that the solubility of curcumin could be enhanced while being solved or encapsulated in some drug porters [5], Thus, we hypothesized that the amphipathic nanoparticles of dendrosome O400 could improve the bioavailability of curcumin thereby escalating its anti-tumor effect. To document this idea, we employed two cancerous cell lines in vitro as well as BALB/c mouse model of fibrosarcoma tumor in vivo to analyze the anti-cancerous activity of dendrosomal curcumin
Acknowledgements
This work is dedicated to the memory of Dr. Prof. Mohammad Nabi Sarbolouki who first constructed dendrosome and presented them to the scientific community. We are deeply grateful to Tarbiat Modares University for funding this research. Also, the authors would like to thank Biomaterials Research Center (BRC) of Tehran University for helpful discussions and Dr. Prof. Barbara Krammer, head of Tumor Biology Department at the University of Salzburg, Austria who assisted us in performing the
References (30)
From exotic spice to modern drug?
Cell
(2007)- et al.
Evaluation of anti-tumor effects of tumor cell lysate enriched by HSP-70 against fibrosarcoma tumor in BALB/c mice
Int Immunopharmacol
(2007) - et al.
The effect of vaccination with the lysate of heat shocked tumor cells on nitric oxide production in BALB/c mice with fibrosarcoma tumor
Cell Biol Int
(2008) - et al.
Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets
Trends Pharmacol Sci
(2009) - et al.
Inhibitory effect of dietary curcumin on skin carcinogenesis in mice
Cancer Lett
(1997) - et al.
Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds
Cancer Lett
(1995) - et al.
Immunomodulatory effects of curcumin: in-vivo
Int Immunopharmacol
(2008) - et al.
Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity
Int Immunopharmacol
(2011) - et al.
Molecular targets of phytochemicals for cancer prevention
Nat Rev Cancer
(2001) - et al.
Curcumin as “curecumin”: from kitchen to clinic
Biochem Pharmacol
(2008)